• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Intracerebral hemorrhage may be an independent risk factor for arterial ischemic events

byJake EngelandMichael Pratte
June 2, 2021
in Cardiology, Chronic Disease, Emergency, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients with an intracerebral hemorrhage (ICH) had an increased risk of ischemic stroke and myocardial infarction events compared to those without a previous ICH.

Evidence Rating Level: 2 (Good)

Study Rundown: Intracerebral hemorrhage (ICH) and arterial ischemic events (AIEs), such as myocardial infarction (MI) and ischemic stroke, have several risk factors in common; however, it is not clear whether ICH independently increases the risk of AIEs. This analysis of four pooled cohort studies examined whether ICH led to increased incidence of AIE. The incidence rate of an AIE was approximately three times higher in those who had a previous ICH compared to those without one. After adjusting for baseline characteristics and anticoagulant medications, there was a two-fold increase in risk for AIE in those with a previous ICH. Given the large sample size (almost 50 000 included participants) from multiple population-based cohorts and adjustment of baseline covariates, this study demonstrated that ICH may be associated with an elevated risk of ischemic strokes and myocardial infarctions. One limitation of this study, however, was that several other measures of risk for cardiovascular events (obesity, peripheral vascular disease, and diet) were not recorded and, therefore, not adjusted for in the analysis.

Click to read the study in JAMA Neurology

Click to read an accompanying editorial in JAMA Neurology

Relevant Reading: Five-year risk of major ischemic and hemorrhagic events after intracerebral hemorrhage

In-Depth [prospective cohort]: This study included 47 866 participants (mean age, 62.2 years) from 4 population-based cohort studies between 1987 and 2007 in the analysis. Participants were followed up until death or the last available follow-up during the study period; median follow-up was 12.7 years (IQR, 7.7-19.5), with the final recorded follow-up on December 31, 2018. The primary outcome was an AIE (MI and/or ischemic stroke), which occurred in 7648 participants (16%). Participants were excluded if they had a previous AIE or an AIE concurrent with the ICH event. The incidence rate of an AIE was 3.6 events per 100 person-years (95% CI, 2.7-5.0) among patients who had an ICH compared to 1.1 events per 100 person-years (95% CI, 1.1-1.2) in those without any previous ICH. ICH was associated with an increased risk of an AIE (HR, 2.3; 95% CI, 1.7-3.1) after adjustment for baseline covariates (patient characteristics, vascular comorbidities, antithrombotic medications). The secondary outcomes were MI and ischemic stroke alone. After adjusting, an ICH event was associated with increased risk of MI (HR, 1.9; 95% CI, 1.2-2.9) and ischemic stroke (HR, 3.1; 95% CI, 2.1-4.5).

RELATED REPORTS

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

Tranexamic acid is unlikely to induce signs suggestive of cerebral ischemia in the treatment of acute intracerebral hemorrhage: TICH-2 study

#VisualAbstract: Effectiveness of sacubitril-valsartan in post-myocardial infarction management compared to ramipril

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute myocardial infarctionintracerebral hemorrhageischemic heart disease
Previous Post

Improvements in therapeutic and managing standards associated with significant reduction in risk of persistent disability in patients with pediatric-onset multiple sclerosis

Next Post

#VisualAbstract: COVID-19 in pregnancy associated with substantially increased maternal and neonatal morbidity and mortality

RelatedReports

Nonpowder gun-related pediatric eye injuries on the rise
Cardiology

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

April 22, 2022
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Emergency

Tranexamic acid is unlikely to induce signs suggestive of cerebral ischemia in the treatment of acute intracerebral hemorrhage: TICH-2 study

March 22, 2022
StudyGraphics

#VisualAbstract: Effectiveness of sacubitril-valsartan in post-myocardial infarction management compared to ramipril

February 10, 2022
Reinnervation of cardiac infarcts decreases subsequent arrhythmia incidence [PreClinical]
Cardiology

Paroxetine does not improve left ventricle ejection fraction at 12 weeks post-anterior myocardial infarction

November 8, 2021
Next Post
#VisualAbstract: ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

#VisualAbstract: COVID-19 in pregnancy associated with substantially increased maternal and neonatal morbidity and mortality

Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress

Association between number of teeth and Alzheimer's Disease risk

No differences in pain between suture and staple C-Section closure

Prophylactic tranexamic acid prevents significant blood loss after cesarean delivery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.